ALFA Finder India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold Telegram alerts alfafinder.com →
Thursday, 12 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Investor Presentation

Innovassynth Technologies (India) Investor Presentation: Key Takeaways

Innovassynth reported sharp Q1FY27 recovery with Revenue of ₹55.99 Cr and 27% EBITDA margin. Strategy focuses on CRDMO expansion in Life Sciences and Specialty Chemicals for US/EU markets.

Highlights
Revenue growth356% YoY increase to ₹55.99 Cr.
MarginsEBITDA margin improved to 27% from -127% YoY and 12% QoQ.
Order book₹165 Cr total: ₹84 Cr Life Sciences, ₹66 Cr CDMO.
Demand visibilityStrong visibility with ₹165 Cr order book as of June 2026.
Management confidenceHigh; citing sustained improvement in business performance and healthy demand.

Growth

Revenue grew 356% YoY to ₹55.99 Cr; PAT turned positive at ₹6.74 Cr vs ₹18.67 Cr loss YoY.

Outlook

Order book of ₹165 Cr provides visibility; planned Life Sciences expansion expected to double capacity.

Risks

Management cited continued logistics-related challenges as a headwind during the quarter.

Source

Investor Presentation filed with BSE, NSE: INOVSYNTH. Summary written with AI assistance from the document.

Read the document ↗

Innovassynth Technologies (India) Ltd: key numbers

Share price
₹169.75
Market cap
₹1,576 Cr
Revenue (annual)
₹102.3 Cr
Net profit (annual)
₹-28.79 Cr
P/E (TTM)
127.3×Sector 32.4×
Promoter holding
75.04%+0.00% QoQ
FII holding
1.13%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Innovassynth Technologies (India) Ltd

All →